期刊
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
卷 13, 期 4, 页码 239-U88出版社
NATURE PORTFOLIO
DOI: 10.1038/nrgastro.2016.7
关键词
-
资金
- Gilead Sciences
- Arrowhead
- Assembly Bioscience
- Janssen
- Novira
- Roche
Chronic HBV infection results in >1 million deaths per year from cirrhosis and liver cancer. No known cure for chronic HBV exists, due in part to the continued presence of transcriptionally active DNA in the nucleus that is not directly targeted by current antiviral therapies. A coordinated approach is urgently needed to advance an HBV cure worldwide, such as those established in the HIV field. We propose the establishment of an International Coalition to Eliminate Hepatitis B Virus (ICE-HBV) to facilitate the formation of international working groups on HBV virology, immunology, innovative tools and clinical trials: to promote awareness and education as well as to drive changes in government policy and ensure funds are channelled to HBV cure research and drug development. With the ICE-HBV in place, it should be possible to enable a HBV cure within the next decade.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据